Anti-Müllerian hormone receptor
Anti-Müllerian hormone receptor (AMHR) is a protein that in humans is encoded by the AMHR2 gene. It is a type of transmembrane receptor that plays a crucial role in the development and function of the reproductive system.
Function[edit]
The Anti-Müllerian hormone receptor is a specific receptor for Anti-Müllerian hormone (AMH), a member of the transforming growth factor-beta (TGF-beta) family. When AMH binds to this receptor, it initiates a series of cellular signaling events that lead to the regression of the Müllerian ducts in male embryos. This process is essential for the normal development of the male reproductive system.
In females, the Anti-Müllerian hormone receptor is involved in the regulation of folliculogenesis, the maturation of the ovarian follicles. It is also used as a clinical marker for ovarian reserve in women undergoing assisted reproductive technologies.
Clinical significance[edit]
Mutations in the AMHR2 gene can lead to persistent Müllerian duct syndrome (PMDS), a rare disorder of sexual development in males. In this condition, males have normal external genitalia but also have a uterus and fallopian tubes, structures that are normally present only in females.
In addition, levels of AMH and its receptor can be used as a diagnostic tool for certain conditions, such as polycystic ovary syndrome (PCOS) and premature ovarian failure.
See also[edit]
References[edit]
 | This protein-related article is a stub. You can help WikiMD by expanding the page. |
 | This gene article is a stub. You can help WikiMD by expanding the page. |
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
Annotated 3D AMHR2 protein showing key motifs
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
